Tofacitinib Treatment in Patients With Active COVID-19 Infection

Alopecia areata is a chronic autoimmune disorder attacking the hair follicle epithelium; hence, causing non-scarring hair loss. It has been found that Janus kinase 3 (JAK3) hyperactivity plays a key role in the pathogenesis of the disease. Tofacitinib is an effective JAK1 and JAK3 inhibitor that can...

Descripción completa

Detalles Bibliográficos
Autores principales: Alajlan, Abdulmajeed M, AlZamil, Lama R, Aseri, Amal M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516018/
https://www.ncbi.nlm.nih.gov/pubmed/34660145
http://dx.doi.org/10.7759/cureus.17957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516018/
https://www.ncbi.nlm.nih.gov/pubmed/34660145
http://dx.doi.org/10.7759/cureus.17957

Ejemplares similares